Key result
Myocardial ischemia on exercise thallium scintigraphy and induced ventricular tachycardia at electrophysiologic study identify patients with hypertrophic cardiomyopathy at high risk for sudden death.
Why the study?
Do risk stratification tests (such as exercise thallium scintigraphy and electrophysiologic study) predict sudden death in patients with hypertrophic cardiomyopathy?
Do risk stratification tests (such as exercise thallium scintigraphy and electrophysiologic study) predict sudden death in patients with hypertrophic cardiomyopathy?
Exercise thallium scintigraphy and electrophysiologic studies are useful for identifying hypertrophic cardiomyopathy patients at high risk for sudden death, while asymptomatic nonsustained ventricular tachycardia on Holter monitoring is not predictive.
Answers are grounded in this paper and cite their sources.
May inform sudden death risk stratification in hypertrophic cardiomyopathy; leaves open prospective validation before practice change.
Patients with hypertrophic cardiomyopathy are at increased risk for sudden death. Recent studies have improved our ability to risk-stratify such patients and have elucidated several potential mechanisms of sudden death and syncope. Certain noninvasive tests, such as signal-averaged electrocardiography and measurements of cardiac autonomic function and QT/QT dispersion, are often abnormal in hypertrophic cardiomyopathy, but are not useful for risk stratification. Myocardial ischemia determined by exercise thallium scintigraphy, however, identifies young patients with hypertrophic cardiomyopathy who are at high risk for cardiac arrest and syncope. Nonsustained ventricular tachycardia on ambulatory Holter monitoring in the absence of symptoms of impaired consciousness is associated with a benign prognosis and is not predictive of sudden death. Conversely, ventricular tachycardia induced at electrophysiologic study identifies adult patients with hypertrophic cardiomyopathy who subsequently experience sudden death. Finally, characterization of the natural history of the genetic defects will increasingly become an integral part of risk evaluation in hypertrophic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Chang et al. (1995) conducted a review in Hypertrophic cardiomyopathy. Risk stratification tests (e.g., exercise thallium scintigraphy, electrophysiologic study) was evaluated on Sudden death and syncope. Myocardial ischemia on exercise thallium scintigraphy and induced ventricular tachycardia at electrophysiologic study identify patients with hypertrophic cardiomyopathy at high risk for sudden death.
Synapse has enriched 10 related papers. Consider them for comparative context: